Sangeeta Bhatia, an Indian-origin scientist at MIT, who has developed artificial human microlivers for drug testing, has won a prestigious $2,50,000 Heinz award for her work in tissue engineering and disease detection.
The Heinz Awards annually recognise individuals for their extraordinary contributions to arts and humanities; environment; human condition; public policy; and technology, the economy, and employment.
About Dr.Sangeeta Bhatia: Dr.Bhatia is a Howard Hughes Medical Institute Investigator and the John J. and Dorothy Wilson Professor at MIT’s Institute for Medical Engineering and Science and Electrical Engineering and Computer Science (EECS). She is a member of the Koch Institute for Integrative Cancer Research, the Ludwig Center for Molecular Oncology, and the Harvard Stem Cell Institute, a Senior member of the Broad Institute, and a Biomedical Engineer at the Brigham & Women's Hospital. Trained as both a physician and engineer, Bhatia’s laboratory is dedicated to leveraging miniaturization tools from the world of semiconductor manufacturing to impact human health. She has pioneered technologies for interfacing living cells with synthetic systems, enabling new applications in tissue regeneration, stem cell differentiation, medical diagnostics and drug delivery. Her multidisciplinary team has developed a broad and impactful range of inventions, including human micro livers which model human drug metabolism, liver disease, and interaction with pathogens, and a suite of communicating nanomaterials that can be used to interrogate, monitor and treat cancer and other diseases. Her work has been profiled broadly such as in Scientific American, the Boston Globe, Popular Science, Forbes, PBS’s NOVA scienceNOW, the Economist and MSNBC.
The Heinz Awards annually recognise individuals for their extraordinary contributions to arts and humanities; environment; human condition; public policy; and technology, the economy, and employment.
Indian-origin scientist at #MIT wins $2,50,000 Heinz award pic.twitter.com/cpFwIpdcYT
— Press Release Watch (@PrReleaseWatch) April 27, 2015
Kudos to @MIT’s Sangeeta Bhatia for winning the Heinz Award. Proud to know her as a friend & now fellow entrepreneur! http://t.co/JNDoSYhxxu
— Kiran Mazumdar Shaw (@kiranshaw) April 27, 2015
About Dr.Sangeeta Bhatia: Dr.Bhatia is a Howard Hughes Medical Institute Investigator and the John J. and Dorothy Wilson Professor at MIT’s Institute for Medical Engineering and Science and Electrical Engineering and Computer Science (EECS). She is a member of the Koch Institute for Integrative Cancer Research, the Ludwig Center for Molecular Oncology, and the Harvard Stem Cell Institute, a Senior member of the Broad Institute, and a Biomedical Engineer at the Brigham & Women's Hospital. Trained as both a physician and engineer, Bhatia’s laboratory is dedicated to leveraging miniaturization tools from the world of semiconductor manufacturing to impact human health. She has pioneered technologies for interfacing living cells with synthetic systems, enabling new applications in tissue regeneration, stem cell differentiation, medical diagnostics and drug delivery. Her multidisciplinary team has developed a broad and impactful range of inventions, including human micro livers which model human drug metabolism, liver disease, and interaction with pathogens, and a suite of communicating nanomaterials that can be used to interrogate, monitor and treat cancer and other diseases. Her work has been profiled broadly such as in Scientific American, the Boston Globe, Popular Science, Forbes, PBS’s NOVA scienceNOW, the Economist and MSNBC.
